These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 9676343)
1. [The effect of different variables on the in vitro dissolution of a theophylline sustained-release preparation]. Fuchs WS; Jakobs R; Grunenberg P; Weiss G; Profitlich T; von Nieciecki A; Klemm FH; Laicher A; Stanislaus F Arzneimittelforschung; 1998 May; 48(5A):552-6. PubMed ID: 9676343 [TBL] [Abstract][Full Text] [Related]
2. [Manufacture and in vitro characterization of a new fluid theophylline sustained-release form. Sachets with microcapsules for administration in a drinkable sustained-release suspension]. Weiss G; Klemm FH; Fuchs WS; Stanislaus F; Zema M; Calanchi M Arzneimittelforschung; 1998 May; 48(5A):604-12. PubMed ID: 9676353 [TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets. Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147 [TBL] [Abstract][Full Text] [Related]
4. [Requirements for product quality of theophylline sustained-release preparations]. Fuchs WS; Hens C; von Nieciecki A Arzneimittelforschung; 1998 May; 48(5A):556-61. PubMed ID: 9676344 [TBL] [Abstract][Full Text] [Related]
5. In vitro release testing of matrices based on starch-methyl methacrylate copolymers: effect of tablet crushing force, dissolution medium pH and stirring rate. Ferrero C; Jiménez-Castellanos MR Int J Pharm; 2014 Jan; 461(1-2):270-9. PubMed ID: 24333902 [TBL] [Abstract][Full Text] [Related]
6. Formulation development and in vitro evaluation of theophylline microcapsules. Ahmad M; Akhtar N; Murtaza G; Hussain SW Pak J Pharm Sci; 2012 Jan; 25(1):15-9. PubMed ID: 22186304 [TBL] [Abstract][Full Text] [Related]
7. [Revalidation of the in vitro specification limits after an in vitro-in vivo correlation]. Pabst G Arzneimittelforschung; 1998 May; 48(5A):584-8. PubMed ID: 9676349 [TBL] [Abstract][Full Text] [Related]
8. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets. Uhumwangho MU; Okor RS Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417 [TBL] [Abstract][Full Text] [Related]
9. [Experience in scaling up the film coating process for theophylline sustained-release pellets in mass production]. Grunenberg P; Lorck C; Jünger H; Laicher A Arzneimittelforschung; 1998 May; 48(5A):547-51. PubMed ID: 9676342 [TBL] [Abstract][Full Text] [Related]
10. Chemical imaging of oral solid dosage forms and changes upon dissolution using coherent anti-Stokes Raman scattering microscopy. Windbergs M; Jurna M; Offerhaus HL; Herek JL; Kleinebudde P; Strachan CJ Anal Chem; 2009 Mar; 81(6):2085-91. PubMed ID: 19209888 [TBL] [Abstract][Full Text] [Related]
11. In-vitro dissolution behavior of some sustained-release theophylline dosage forms. Lin SY; Yang JC Pharm Acta Helv; 1989; 64(8):236-40. PubMed ID: 2780758 [TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetics of a new fluid theophylline sustained-release drug form. Microcapsules in a sachet]. Fuchs WS; Weiss G; von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M Arzneimittelforschung; 1998 May; 48(5A):612-7. PubMed ID: 9676354 [TBL] [Abstract][Full Text] [Related]
13. Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form. Jantratid E; De Maio V; Ronda E; Mattavelli V; Vertzoni M; Dressman JB Eur J Pharm Sci; 2009 Jun; 37(3-4):434-41. PubMed ID: 19491035 [TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms. Goole J; Vanderbist F; Amighi K Int J Pharm; 2007 Apr; 334(1-2):35-41. PubMed ID: 17097841 [TBL] [Abstract][Full Text] [Related]
15. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation. Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270 [TBL] [Abstract][Full Text] [Related]
17. Critical dissolution tests of oral systems based on statistically designed experiments. III. In vitro/in vivo correlation for multiple-unit capsules of paracetamol based on PLS modeling. Abuzarur-Aloul R; Gjellan K; Sjölund M; Graffner C Drug Dev Ind Pharm; 1998 Apr; 24(4):371-83. PubMed ID: 9876598 [TBL] [Abstract][Full Text] [Related]
18. Formulation study and drug release mechanism of a new theophylline sustained-release preparation. Hayashi T; Kanbe H; Okada M; Suzuki M; Ikeda Y; Onuki Y; Kaneko T; Sonobe T Int J Pharm; 2005 Nov; 304(1-2):91-101. PubMed ID: 16154302 [TBL] [Abstract][Full Text] [Related]
19. Per-oral controlled release dosage form of theophylline using soybean protein. Machida Y; Tokumura T; Nagai T Drug Des Deliv; 1987 Feb; 1(3):187-92. PubMed ID: 3509332 [TBL] [Abstract][Full Text] [Related]
20. Determination of intraluminal theophylline concentrations after oral intake of an immediate- and a slow-release dosage form. Brouwers J; Ingels F; Tack J; Augustijns P J Pharm Pharmacol; 2005 Aug; 57(8):987-96. PubMed ID: 16102254 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]